China National Medicines Corporation Ltd. (SHA:600511)
China · Delayed Price · Currency is CNY 27.34
-0.28 (-1.01%)
Oct 22, 2026, 3:00 PM CST
SHA:600511 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 53,693 | 52,468 | 50,597 | 49,696 | 45,499 | 46,469 |
Revenue Growth | 3.36% | 3.70% | 1.81% | 9.22% | -2.09% | 15.08% |
Gross Profit Gross Profit Growth | 3,521 | 3,454 | 3,594 | 3,992 | 3,817 | 3,621 |
Operating Income Operating Income Growth | 2,078 | 2,026 | 2,105 | 2,372 | 2,319 | 2,055 |
Net Income Net Income Growth | 1,981 | 1,997 | 2,000 | 2,146 | 1,964 | 1,754 |
Earnings Per Share EPS Growth | 2.63 | 2.65 | 2.65 | 2.84 | 2.60 | 2.32 |
EPS Growth | -1.52% | -0.18% | -6.80% | 9.27% | 11.97% | 26.86% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Commercial Segment Commercial Segment Growth | 51,694 |
Others Others Growth | 1,129 |
Intersegment Offset Intersegment Offset Growth | -354.9 |
Total Total Growth | 52,468 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 8,162 | 11,482 | 10,886 | 10,926 | 8,896 | 7,316 |
Total Debt Total Debt Growth | 504.08 | 516.28 | 845.95 | 547.5 | 515.13 | 701.93 |
Net Cash (Debt) Net Cash Growth | 7,657 | 10,965 | 10,040 | 10,378 | 8,381 | 6,614 |
Net Cash Growth | 8.23% | 9.22% | -3.26% | 23.83% | 26.72% | 21.97% |
Net Cash Per Share Net Cash Per Share Growth | 10.15 | 14.53 | 13.31 | 13.76 | 11.11 | 8.77 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,649 | 2,006 | 1,659 | 2,727 | 2,395 | 1,957 |
Capital Expenditures CapEx Growth | -69.26 | -68.19 | -130.77 | -145.12 | -129.78 | -95.07 |
Free Cash Flow Free Cash Flow Growth | 1,580 | 1,937 | 1,528 | 2,582 | 2,265 | 1,862 |
Free Cash Flow Growth | 178.20% | 26.76% | -40.80% | 13.96% | 21.64% | 51.09% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 6.56% | 6.58% | 7.10% | 8.03% | 8.39% | 7.79% |
Operating Margin | 3.87% | 3.86% | 4.16% | 4.77% | 5.10% | 4.42% |
Pretax Margin | 4.80% | 4.96% | 5.24% | 5.90% | 5.91% | 5.26% |
Profit Margin | 3.69% | 3.81% | 3.95% | 4.32% | 4.32% | 3.77% |
FCF Margin | 2.94% | 3.69% | 3.02% | 5.20% | 4.98% | 4.01% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.800 | 0.800 | 0.800 | 0.854 | 0.782 | 0.700 |
Dividend Per Share Growth | 0% | 0% | -6.32% | 9.21% | 11.71% | 27.27% |
Dividend Yield | 2.93% | 2.78% | 2.34% | 2.98% | 2.80% | 2.22% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 22, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.42 | 10.86 | 12.91 | 10.06 | 10.72 | 13.56 |
Forward PE | 9.94 | 10.25 | 10.71 | 8.91 | 10.01 | 12.87 |
P/FCF Ratio | 13.19 | 11.20 | 16.89 | 8.37 | 9.29 | 12.77 |
PS Ratio | 0.39 | 0.41 | 0.51 | 0.44 | 0.46 | 0.51 |